Video Experimental Relacionado
Updated: Jan 27, 2026
08:08
Simulator Training for Endovascular Neurosurgery
Published on: May 6, 2020
4.1K
Diversidad racial y étnica en ensayos de trombectomía endovascular
Gisele Sampaio Silva1,2, Eva Rocha1, Amol Mehta3
1Department of Neurology and Neurosurgery Division of Vascular Neurology and Neurointensive Care Universidade Federal de São Paulo (UNIFESP) São Paulo Brazil.
Stroke (Hoboken, N.J.)
|January 26, 2026
Resumen
Los adultos negros e hispanos experimentan mayores riesgos de ictus y mortalidad. La subutilización de tratamientos como la trombectomía endovascular y la infrarrepresentación en los ensayos clínicos resaltan importantes disparidades raciales en la atención del ictus.
Área de la Ciencia:
- Neurología
- Salud Pública
- Investigación Clínica
Sus antecedentes:
- La carga del ictus isquémico agudo afecta desproporcionadamente a los adultos negros, con tasas de incidencia y mortalidad más altas.
- La terapia trombolítica y la trombectomía endovascular se utilizan menos en adultos negros e hispanos en los EE. UU.
- Las minorías raciales y étnicas siguen estando infrarrepresentadas en los ensayos clínicos de EE. UU. a pesar de las iniciativas federales de diversidad.
Objetivo del estudio:
- Revisar las disparidades raciales y étnicas en la incidencia y la atención clínica del ictus, centrándose en la trombectomía endovascular.
- Describir la notificación de la diversidad en los ensayos de trombectomía endovascular.
- Identificar oportunidades y barreras para aumentar la diversidad en estos ensayos.
Principales métodos:
- Revisión temática de la literatura existente sobre disparidades en el ictus.
- Análisis de datos sobre la utilización de la trombectomía endovascular y la diversidad de los ensayos clínicos.
- Examen de las normas mundiales de notificación de raza y etnia.
Principales resultados:
- Existen disparidades significativas en la incidencia de ictus, la utilización del tratamiento y la representación en ensayos clínicos para adultos negros e hispanos.
- La falta de informes estandarizados de raza y etnia a nivel mundial complica la evaluación de la diversidad en los ensayos.
- La infrarrepresentación persiste a pesar de los esfuerzos por promover la diversidad en la investigación.
Conclusiones:
- Es fundamental abordar las disparidades raciales y étnicas en la atención del ictus, en particular para la trombectomía endovascular.
- Se necesitan informes estandarizados y estrategias específicas para mejorar la diversidad en los ensayos clínicos.
- Es esencial superar las barreras para garantizar un acceso equitativo a los tratamientos para el ictus y la participación en la investigación.
Videos de Conceptos Relacionados
01:27Ethnic Identity within a Larger Culture
237
Adolescents from ethnic minority backgrounds face a multifaceted journey in forming their identities, shaped by the intersections of cultural expectations and personal exploration. For these adolescents, identity formation involves not only typical developmental challenges but also navigating the perceptions and attitudes of the majority culture. As they grow, adolescents in ethnic minority groups often become increasingly aware of stereotypes, social biases, and discrimination, all of which...
237
01:16Clinical Trials
10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.2K
01:11Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
01:12Trial and Error and Algorithm
403
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
403
01:30Diversity of Archaea I
569
Archaea, a domain of single-celled microorganisms, are classified into five major phyla based on genetic and biochemical characteristics: Euryarchaeota, Crenarchaeota, Thaumarchaeota, Korarchaeota, and Nanoarchaeota. Among these, the phylum Euryarchaeota is notable for its remarkable diversity in morphology, metabolism, and ecological adaptations.Morphological and Metabolic DiversityMembers of Euryarchaeota exhibit a variety of cellular shapes, including rods and cocci. Their metabolic pathways...
569
01:24Diversity of Archaea II
469
Archaea, one of the three domains of life, exhibit remarkable diversity and adaptability, thriving in both extreme and moderate environments. Historically, most identified archaea have been classified into two major phyla: Euryarchaeota and Crenarchaeota. However, recent molecular studies have expanded this classification to include three additional phyla: Thaumarchaeota, Nanoarchaeota, and Korarchaeota, each exhibiting unique characteristics and ecological roles.Thaumarchaeota: Mesophiles...
469